| Primary |
| Epilepsy |
38.7% |
| Convulsion |
20.9% |
| Product Used For Unknown Indication |
14.0% |
| Status Epilepticus |
5.7% |
| Partial Seizures |
4.6% |
| Grand Mal Convulsion |
3.2% |
| Complex Partial Seizures |
2.1% |
| Convulsion Prophylaxis |
1.9% |
| Drug Use For Unknown Indication |
1.3% |
| Juvenile Myoclonic Epilepsy |
1.1% |
| Petit Mal Epilepsy |
1.0% |
| Seizures |
0.8% |
| Myoclonic Epilepsy |
0.8% |
| Temporal Lobe Epilepsy |
0.7% |
| Hypertension |
0.7% |
| Depression |
0.6% |
| Pain |
0.5% |
| Prophylaxis |
0.5% |
| Post-traumatic Epilepsy |
0.5% |
| Glioblastoma Multiforme |
0.4% |
|
| Convulsion |
16.8% |
| Pregnancy |
13.4% |
| Product Substitution Issue |
13.0% |
| Status Epilepticus |
6.1% |
| Thrombocytopenia |
4.9% |
| Drug Ineffective |
4.4% |
| Grand Mal Convulsion |
3.8% |
| Drug Exposure During Pregnancy |
3.7% |
| Maternal Exposure During Pregnancy |
3.5% |
| Therapeutic Response Unexpected With Drug Substitution |
3.4% |
| Epilepsy |
3.3% |
| Condition Aggravated |
3.1% |
| Vomiting |
3.0% |
| Abortion Spontaneous |
2.8% |
| Myoclonus |
2.8% |
| Somnolence |
2.6% |
| Death |
2.5% |
| Product Quality Issue |
2.4% |
| Foetal Exposure During Pregnancy |
2.2% |
| Maternal Drugs Affecting Foetus |
2.2% |
|
| Secondary |
| Epilepsy |
28.7% |
| Convulsion |
18.7% |
| Product Used For Unknown Indication |
17.9% |
| Status Epilepticus |
8.9% |
| Drug Use For Unknown Indication |
5.3% |
| Partial Seizures |
3.9% |
| Grand Mal Convulsion |
3.7% |
| Complex Partial Seizures |
1.7% |
| Infantile Spasms |
1.6% |
| Ill-defined Disorder |
1.4% |
| Drug Exposure During Pregnancy |
1.2% |
| Convulsion Prophylaxis |
1.1% |
| Bipolar Disorder |
1.0% |
| Myoclonus |
0.8% |
| Hypertension |
0.8% |
| Abnormal Behaviour |
0.7% |
| Pain |
0.7% |
| Foetal Exposure During Pregnancy |
0.7% |
| Hiv Infection |
0.7% |
| Parkinson's Disease |
0.7% |
|
| Convulsion |
11.7% |
| Drug Ineffective |
10.9% |
| Status Epilepticus |
10.7% |
| Grand Mal Convulsion |
8.2% |
| Epilepsy |
5.3% |
| Maternal Exposure During Pregnancy |
4.6% |
| Death |
4.1% |
| Suicide Attempt |
4.1% |
| Somnolence |
3.9% |
| Toxicity To Various Agents |
3.9% |
| Spina Bifida |
3.8% |
| Thrombocytopenia |
3.8% |
| Pregnancy |
3.6% |
| Weight Increased |
3.5% |
| Completed Suicide |
3.1% |
| Fatigue |
3.1% |
| Nausea |
3.1% |
| Product Substitution Issue |
3.1% |
| Maternal Drugs Affecting Foetus |
2.8% |
| Drug Exposure During Pregnancy |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.0% |
| Epilepsy |
20.5% |
| Drug Use For Unknown Indication |
10.7% |
| Convulsion |
10.6% |
| Hypertension |
3.9% |
| Status Epilepticus |
3.1% |
| Prophylaxis |
2.8% |
| Glioblastoma |
2.4% |
| Pain |
2.3% |
| Depression |
2.1% |
| Glioblastoma Multiforme |
2.1% |
| Partial Seizures |
2.0% |
| Multiple Sclerosis |
1.9% |
| Hiv Infection |
1.8% |
| Complex Partial Seizures |
1.4% |
| Rheumatoid Arthritis |
1.1% |
| Convulsion Prophylaxis |
1.1% |
| Anxiety |
1.1% |
| Nausea |
1.1% |
| Grand Mal Convulsion |
1.0% |
|
| Convulsion |
15.0% |
| Epilepsy |
8.5% |
| Vomiting |
8.1% |
| Thrombocytopenia |
5.7% |
| Status Epilepticus |
5.6% |
| Death |
5.1% |
| Tremor |
4.4% |
| Urinary Tract Infection |
4.4% |
| Weight Increased |
4.3% |
| Grand Mal Convulsion |
4.1% |
| Nausea |
4.1% |
| Pneumonia |
3.9% |
| Weight Decreased |
3.6% |
| Drug Ineffective |
3.5% |
| White Blood Cell Count Decreased |
3.5% |
| Renal Failure Acute |
3.3% |
| Somnolence |
3.3% |
| Pyrexia |
3.2% |
| Rash |
3.2% |
| Syncope |
3.1% |
|
| Interacting |
| Partial Seizures |
21.6% |
| Epilepsy |
18.7% |
| Convulsion |
7.6% |
| Encephalitis |
7.0% |
| Small Cell Lung Cancer Metastatic |
4.7% |
| Drug Use For Unknown Indication |
4.1% |
| Complex Partial Seizures |
3.5% |
| Hypothyroidism |
3.5% |
| Hypoxic-ischemic Encephalopathy |
3.5% |
| Schizophrenia |
3.5% |
| Seizures |
3.5% |
| Acute Lymphocytic Leukaemia |
2.3% |
| Astrocytoma |
2.3% |
| Chemotherapy |
2.3% |
| Glioblastoma |
2.3% |
| Vomiting |
2.3% |
| Abnormal Behaviour |
1.8% |
| Cerebrovascular Accident |
1.8% |
| Hypertension |
1.8% |
| Maternal Exposure Timing Unspecified |
1.8% |
|
| Drug Interaction |
25.0% |
| Epilepsy |
7.7% |
| Convulsion |
5.8% |
| Fatigue |
5.8% |
| Somnolence |
5.8% |
| Tremor |
5.8% |
| Vomiting |
5.8% |
| Ataxia |
3.8% |
| Hepatic Failure |
3.8% |
| Mental Disorder |
3.8% |
| Motor Dysfunction |
3.8% |
| Pregnancy On Oral Contraceptive |
3.8% |
| Sudden Unexplained Death In Epilepsy |
3.8% |
| Toxic Encephalopathy |
3.8% |
| Agitation |
1.9% |
| Balance Disorder |
1.9% |
| Convulsive Threshold Lowered |
1.9% |
| Crying |
1.9% |
| Death |
1.9% |
| Diplopia |
1.9% |
|
